Invention Grant
- Patent Title: Peptide having anti-diabetic activity and use thereof
- Patent Title (中): 具有抗糖尿病活性的肽及其用途
-
Application No.: US13123784Application Date: 2009-10-28
-
Publication No.: US08691949B2Publication Date: 2014-04-08
- Inventor: Kyoichi Kagawa , Chizuko Fukuhama , Chunning Tong , Yuka Sasakawa
- Applicant: Kyoichi Kagawa , Chizuko Fukuhama , Chunning Tong , Yuka Sasakawa
- Applicant Address: JP Osaka
- Assignee: MG Pharma Inc.
- Current Assignee: MG Pharma Inc.
- Current Assignee Address: JP Osaka
- Agency: Roylance, Abrams, Berdo & Goodman, L.L.P.
- Priority: JP2008-280031 20081030
- International Application: PCT/JP2009/068504 WO 20091028
- International Announcement: WO2010/050508 WO 20100506
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K5/00 ; C07K7/00 ; C07K16/00 ; C07K17/00 ; C07K1/00 ; A61P3/10 ; A61P7/12 ; A61P3/08 ; A61K38/28 ; A61K51/00
Abstract:
The present invention provides a composition (a blood glucose increase inhibitor) that has an effect of lowering blood glucose level in a hyperglycemic patient and that is therefore used to reduce blood glucose level in the patient. The present invention further provides a composition that is used to prevent or treat diseases caused by hyperglycemia, in particular, diabetes and diabetic complications (a composition for preventing or treating diseases caused by hyperglycemia, an antidiabetic), based on the above-mentioned effect. A feature of the present invention is using a peptide consisting of the amino acid sequence of Leu-Ser-Glu-Leu as an active ingredient.
Public/Granted literature
- US20110201551A1 PEPTIDE HAVING ANTI-DIABETIC ACTIVITY AND USE THEREOF Public/Granted day:2011-08-18
Information query
IPC分类:
